Latest News
STAT+: Trump administration restored funding for major diabetes study. The pause still set researchers back
The Trump administration’s restored federal research funding to Columbia University's landmark diabetes study. But the impact of the cuts are lasting.
STAT+: Alnylam’s hypertension treatment did not significantly lower blood pressure in mid-stage study
An investigational therapy from Alnylam did not significantly lower blood pressure in a key Phase 2 trial, new data show, but the drug is being advanc...
Opinion: How the U.S. health system can clear up confusion surrounding seasonal vaccines
Vaccines must be easy to get, free at the point of care, and clearly recommended, writes former NYC Health Commissioner Dave A. Chokshi.
STAT+: Abridge CEO downplays impact of Epic’s new AI on call with customers
Exclusive: Abridge's CEO downplays the impact of Epic’s new AI products on a call with hospital customers.
STAT+: Cytokinetics drug yielded benefits over common therapy in patients with heart condition, study shows
An experimental medicine from Cytokinetics showed strong results in patients newly diagnosed with a common, inherited heart condition, according to ne...
Opinion: Public health leader: Susan Monarez must be reinstated at the CDC
Restoring Susan Monarez as CDC director "will serve as a desperately needed check on Kennedy’s power," writes public health leader Georges Benjamin.
More fallout from CDC director’s firing
In today's Morning Rounds newsletter: the fallout from the CDC director’s ouster continues, Kennedy consolidates his power, and more.
STAT+: Pharmalittle: We’re reading about Lilly and a China tech giant, Cassidy and a CDC vaccine panel, and more
The chair of the U.S. Senate health committee called for delaying a federal vaccine advisory panel meeting after a mass exodus of CDC leaders
What the CDC lost: a closer look at the top-ranking officials who have quit
Here is a closer look at the top-ranking officials who resigned from the CDC this week.
Opinion: Dental care is increasingly under threat in the U.S.
The anti-fluoride movement comes when dental care is already increasingly unaffordable and out of reach for millions of Americans — 72 million, to be...
STAT+: Trump administration restored funding for major diabetes study. The pause still set researchers back
STAT+: Alnylam’s hypertension treatment did not significantly lower blood pressure in mid-stage study
Opinion: How the U.S. health system can clear up confusion surrounding seasonal vaccines
STAT+: Abridge CEO downplays impact of Epic’s new AI on call with customers
STAT+: Cytokinetics drug yielded benefits over common therapy in patients with heart condition, study shows
Opinion: Public health leader: Susan Monarez must be reinstated at the CDC
More fallout from CDC director’s firing
STAT+: Pharmalittle: We’re reading about Lilly and a China tech giant, Cassidy and a CDC vaccine panel, and more
What the CDC lost: a closer look at the top-ranking officials who have quit
Opinion: Dental care is increasingly under threat in the U.S.
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago